TNFSF9 and pancreatic adenocarcinoma: In short, A02 supertype combined with B62-positivity and B44-negativity probably co-participated in contributing to the unfavorable immune contexture for recurrent PAAD involved in depressed expression of HLA-A/TLR8, and increased TNFSF9 expression along with weakened antitumor immunity.